Herz Und Diabeteszentrum NRW Bad Oeynhausen Universitaetsklinik Der Ruhr-Universitaet Bochum — Clinical Trial Site

36 Registered trials

17 Currently recruiting

Organisation

Herz Und Diabeteszentrum NRW Bad Oeynhausen Universitaetsklinik Der Ruhr-Universitaet Bochum

Location

Bad Oeynhausen, Germany

Identifier

ORG-100016632

Address

Georgstrasse 11, Innenstadt, 32545, Germany

Departments

#2120: Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
#3474: Klinik für Allgemeine und Interventionelle Kardiologie / Angiologie
2306: Diabeteszentrum Forschung
3474: Klinik für Allgemeine und Interventionelle Kardiologie / Angiologie
7004: Herz- und Diabeteszentrum NRW
Clinic for Diabetology and Endocrinology
Clinic for General and Interventional Cardiology/Angiology
Diabeteszentrum Forschung
endocrinology,diabetology
Herz- und Diabeteszentrum Nordrhein-Westfalen
Herz- und Diabeteszentrum NRW
Herz- und Diabeteszentrum NRW - Bad Oeynhausen - Forschungsleitung Diabeteszentrum
Institute of Anesthesiology and pain therapy
Klinik fuer Diabetologie, Endokrinologie und Gastroenterologie
Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie
Klinik für Diabetologie und Endokrinologie
Klinik für Diabetologie und Endokrinologie, Diabeteszentrum
Klinik für Electrophysiologie/Rhythmologie
Klinik für Kinderkardiologie und angeborene Herzfehler
N/A
NA
Nuclear Medicine
Universitätsklinik der Ruhr-Universität Bochum

Clinical trials at this site (36)

Search interface

AMAZE 8: A research study investigating how well the medicine NNC0487-0111 compared to semaglutide helps people with excess body weight and … Recruiting

2024-520446-31-00 Participants with overweight or obesity, and type 2 dia 5 2026-05-27
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
A Phase 2, Multi-center, Randomized, Dose-Ranging, Placebo-Controlled, Double-blind Study of the Relaxin Agonist R2R01 in Patients at High R… Recruiting

2025-523037-25-00 Patients at high risk for Cardiac Surgery Associated – 4 2026-03-10
CLEOPATTRA: A research study to look at the effects of treatment with a medicine called coramitug (NNC6019-0001) in people with heart failur… Recruiting

2024-518899-31-00 Variant or wild-type transthyretin (TTR) amyloid cardio 5 2025-12-19
A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight and type 2 diabetes Recruiting

2025-523106-32-00 Obesity or Overweight and Type 2 Diabetes 5 2026-05-25
A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight without type 2 diabetes. Recruiting

2025-523104-71-00 Obesity or Overweight Without Type 2 Diabetes 5 2026-05-08
AMAZE 1: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight lose weight Recruiting

2024-520440-42-00 Obesity 5 2026-05-07
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
A Clinical Trial of Tirzepatide (LY3298176) in Subjects With Overweight or Obesity and PCOS-related Ovarian Dysfunction (PERIODS) Recruiting

2024-515982-32-00 Overweight or Obesity 6 2025-12-09
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non… Recruiting

2024-515125-28-00 Non-obstructive hypertrophic cardiomyopathy 4 2025-12-08
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig… Recruiting

2025-520519-14-00 Atherosclerotic Cardiovascular Disease 5 2025-09-03
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy Recruiting

2024-514689-38-01 Pain Associated With Diabetic Peripheral Neuropathy 4 2025-05-12
Maternal oxygen therapy during pregnancy for unborn babies with underdeveloped structures on the left side of the heart Recruiting

2024-512679-11-00 unborn baby with developmental disorder of the left sid 5 2025-04-25
A Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel 18F-labelled Tracer, SYN2, for Positron Emis… Recruiting

2023-506971-89-00 Coronary Artery Disease 5 2024-01-25
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A clinical trial to learn more about the effects of DII235 in people with high levels of lipoprotein(a) Ended

2025-521912-21-00 Cardiovascular risk reduction in participants with elev 4 2026-01-26
A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination wi… Ended

2024-519945-31-00 Type 1 Diabetes 5 2025-08-21
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARIT… Ended

2024-515523-11-00 Chronic Weight Management 5 2025-06-09
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MA… Ended

2024-515524-36-00 Chronic Weight Management 5 2025-05-30
REIMAGINE 5: A research study to see how much CagriSema (1.0 mg once weekly) lowers blood sugar and body weight compared to tirzepatide (5 m… Ended

2023-509600-15-00 Type 2 Diabetes 5 2024-10-18
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended

2023-506457-38-00 Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23